OMB
No.:
0925-0775 |
Please
complete the following document and send to:
icdchelpdesk@mail.nih.gov.
Please include a narrative describing your study and its scientific
benefit for inclusion in the ICDC.
Please include the following information along with the narrative:
Name/Identifier of Study
Grant ID and funding source (if applicable)
IACUC/IRB approval numbers (if applicable)
Scientific Point of Contact (Name, Phone, Email)
Data Manager Point of Contact (Name, Phone, Email)
Data access policy (choose one): Open-access – no-embargo, Controlled-access – no embargo, Open-access – embargo, Controlled-access - embargo
Cancer type(s) included in study
Number of subjects included in study
Sample Source (e.g., CCOGC, other biospecimen repository, self-collected) - if other than self-collected, those identifiers will be required during submission
If self-collected, was a replicate sample also submitted to another biospecimen repository (e.g., CCOGC). If so, those identifiers will be required during submission.
Data types included in study (check all that apply): Imaging, genomics, proteomics, immunology, clinical, other (specify)
Amount of data (in TB)
The overall scientific benefit of including this study in the ICDC prototype
Any publications associated with this study, if any
Time constraints on processing/loading/releasing the data
Data standards used, if any (e.g., SEND)
Anticipated budget needed to prepare data set for submission
Please attach (if available):
1. Data Dictionary specific to study
2. Data Model/Schema diagram indicating how collected data relates to subjects, visits, samples, etc.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Beyers, Matthew (NIH/NCI) [C] |
File Modified | 0000-00-00 |
File Created | 2023-08-26 |